Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Clin Rheumatol. 2017 Nov 14;37(2):415–422. doi: 10.1007/s10067-017-3911-3

Table 3.

Laboratory Data and Biomarkers

Lab Value Patients with ReA (n=32) Mean ± SD Controls (n=32) Mean ± SD p-value Univariate β coeff. (95% CI) Age-and-sex adjusted β coeff. (95% CI)
Sedimentation rate 21.44 ± 25.25 20.19±23.11 NS −1.25 (−13.35, 10.85) 2.66 (−9.14, 14.46)
Total cholesterol 153.94±39.62 188.78±48.76 0.0008 34.84 (12.64, 57.04) 32.47 (9.92, 55.01)
High density lipoprotein 55.76±15.30 60.07±17.43 NS 4.31 (−3.90, 12.50) 5.60 (−2.81, 14.01)
Low density lipoprotein 71.8±34.0 89.33±31.71 0.045 17.53 (1.12 33.96) 15.46 (−1.50, 32.41)
Triglycerides 131.53±49.91 180.06±115.80 NS 48.53 (3.97, 93.09) 40.10 (−3.60, 83.8)
Hemoglobin 5.74±1.68 5.25±0.73 NS −0.48 (−1.13, 0.16) −0.28 (−0.89, 0.33)
Glucose 95.94±41.65 91.88±37.37 NS −4.06 (−23.84, 15. 71) −0.90 (−20.84 19.04)
Cathepsin K (ng/mL) 2.70±0.95 2.17±0.61 0.028 −0.53 (−0.93, −0.13) −0.51 (−0.92, −0.09)
Creatinine (pg/mL) 0.73 ± 0.14 0.78 ± 0.17 NS 0.05 (−0.03, 0.13) 0.004 (−0.05, 0.06)
hsCRP (mg/dL) 4.17±5.34 2.77 ± 3.87 0.03 −1.40 (−3.76, 0.96) −1.11 (−3.54, 1.33)
DKK-1(pg/mL) 3416.16 ± 1388.72 3069.59 ± 1204.33 NS −346.56 (−996.13, 303.00) −106.40 (−725.51, 512.71)
MMP-3 (ng/mL) 14.14 ±9.16 13.07 ± 6.58 NS −1.08 (−5.06 2.91) −3.0 (−6.42, 0.43)
OPG (pmol/L) 6.12 ±1.84 5.24 ± 1.27 NS −0.88(−1.67, −0.09) −0.65 (−1.42, 0.13)
Sclerostin (pg/mL) 179.73 ±75.57 171.00 ± 46.55 NS −8.72 (−40.09, 22.64) −2.98 (−32.52, 26.56)
sRANKL (pmol/L) 530.88 ± 511.01 778.63 ± 713.17 NS 247.74 (−62.39, 557.77) 298.18 (−9.72, 606.09)

HLA typing

HLA-A2 (%) 14 (44 %) 20 (63 %) NS
HLA-B35 (%) 23 (72 %) 19 (59 %) NS
HLA-C7 (%) 17 (53 %) 17 (53 %) NS
HLA-B27 (%) 2 (6 %) 2 (6 %) NS
HLA-B15 (%) 2 (6 %) 2 (6 %) NS
*

p-values were generated using the Wilcoxan Rank Sum test for non-parametric data.